Completion Rates of Treatment for Latent Tuberculosis Infection in Quebec, Canada From 2006 to 2010

[1] Hirsch-Moverman Y(2008)Adherence to treatment for latent tuberculosis infection: Systematic review of studies in the US and Canada Int J Tuberc Lung Dis 12 1235-54

[2] Daftary A(2003)Tuberculosis contact investigations: Outcomes in selected areas of the United States, 1999 Int J Tuberc Lung Dis 7 S384-S390

[3] Franks J(2002)Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States South Med J 95 414-20

[4] Colson PW(2012)Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City Clin Infect Dis 54 1287-95

[5] Jereb J(2012)Moving toward tuberculosis elimination: Implementation of statewide targeted tuberculin testing in Tennessee Am J Respir Crit Care Med 186 273-79

[6] Etkind SC(2004)Cultural case management of latent tuberculosis infection Int J Tuberc Lung Dis 8 76-82

[7] Joglar OT(2004)Treatment completion and costs of a randomized trial of Rifampin for 4 months versus Isoniazid for 9 months Am J Respir Crit Care Med 170 445-49

[8] Moore M(2006)Enhancement of treatment completion for latent tuberculosis infection with 4 months of Rifampin Chest 130 1712-17

[9] Taylor Z(2006)Improved adherence and less toxicity with Rifampin vs Isoniazid for treatment of latent tuberculosis: A retrospective study Arch Intern Med 166 1863-70

[10] Reichler MR(2010)Latent TB infection treatment acceptance and completion in the United States and Canada Chest 137 401-9

[1] Hirsch-Moverman Y(2008)Adherence to treatment for latent tuberculosis infection: Systematic review of studies in the US and Canada Int J Tuberc Lung Dis 12 1235-54

[2] Daftary A(2003)Tuberculosis contact investigations: Outcomes in selected areas of the United States, 1999 Int J Tuberc Lung Dis 7 S384-S390

[3] Franks J(2002)Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States South Med J 95 414-20

[4] Colson PW(2012)Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City Clin Infect Dis 54 1287-95

[5] Jereb J(2012)Moving toward tuberculosis elimination: Implementation of statewide targeted tuberculin testing in Tennessee Am J Respir Crit Care Med 186 273-79

[6] Etkind SC(2004)Cultural case management of latent tuberculosis infection Int J Tuberc Lung Dis 8 76-82

[7] Joglar OT(2004)Treatment completion and costs of a randomized trial of Rifampin for 4 months versus Isoniazid for 9 months Am J Respir Crit Care Med 170 445-49

[8] Moore M(2006)Enhancement of treatment completion for latent tuberculosis infection with 4 months of Rifampin Chest 130 1712-17

[9] Taylor Z(2006)Improved adherence and less toxicity with Rifampin vs Isoniazid for treatment of latent tuberculosis: A retrospective study Arch Intern Med 166 1863-70

[10] Reichler MR(2010)Latent TB infection treatment acceptance and completion in the United States and Canada Chest 137 401-9